Cigna Group stock was falling sharply after the health insurer missed quarterly earnings estimates and issued light guidance ...
Cigna Group plans to make changes to help lower out-of-pocket cost of prescription drugs, the company said on Wednesday, as ...
Raymond James analyst John Ransom lowered the firm’s price target on Cigna (CI) to $360 from $415 and keeps a Strong Buy rating on the shares.
Cigna Group CEO David Cordani said the company will make investments this year to improve patient and provider experiences ...
Shares of Cigna ( CI -8.00%) were dropping Thursday. The stock was down 8.4% as of 1:20 p.m. ET but had lost as much as 11.3% ...
Oppenheimer lowered the firm’s price target on Cigna (CI) to $375 from $400 and keeps an Outperform rating on the shares. The firm notes ...
Cigna Group plans to limit patients’ out-of-pocket expenses for medications as the insurer faces pressure from Washington ...
Cigna blamed lower-than-expected fourth-quarter returns on its stop-loss insurance business that insures employers from ...
Bloomfield-based Cigna announced this week a new initiative that aims to reduce out-of-pocket prescription-drug costs and make those costs more transparent.
With all the hype around AI, business partners and legal professionals are scrambling to understand, adapt, and possibly implement the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback